Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILGAVIMAB\TIXAGEVIMAB for Immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where CILGAVIMAB\TIXAGEVIMAB was used for Immunisation.

Most Reported Side Effects for CILGAVIMAB\TIXAGEVIMAB

Side Effect Reports % Deaths Hosp.
Covid-19 521 24.0% 103 365
Drug ineffective 123 5.7% 16 75
Product use issue 94 4.3% 26 42
Fatigue 86 4.0% 2 16
Headache 86 4.0% 4 16
Dyspnoea 84 3.9% 9 36
Pyrexia 81 3.7% 4 48
Nausea 68 3.1% 0 17
Dizziness 64 3.0% 1 18
Breakthrough covid-19 51 2.4% 6 34
Pneumonia 49 2.3% 8 34
Atrial fibrillation 48 2.2% 3 31
Death 48 2.2% 48 3
Cough 47 2.2% 2 13
Pruritus 46 2.1% 0 6

Other Indications for CILGAVIMAB\TIXAGEVIMAB

Covid-19 prophylaxis (1,105) Covid-19 (287) Covid-19 treatment (146) Immunodeficiency (76) Prophylaxis (57) Product used for unknown indication (30) Immunosuppression (15) Renal transplant (14) Covid-19 immunisation (12) Chronic lymphocytic leukaemia (11)

Other Drugs Used for Immunisation

INFLUENZA VIRUS VACCINE (560) PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281) COVID-19 VACCINE NOS (269) TOZINAMERAN (207) MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148) PNEUMOCOCCAL VACCINE POLYVALENT (140) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123) AD26.COV2.S (113) STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)

Related Pages

CILGAVIMAB\TIXAGEVIMAB Full Profile All Immunisation Drugs CILGAVIMAB\TIXAGEVIMAB Demographics CILGAVIMAB\TIXAGEVIMAB Timeline